explore -WSS

explore

author：leisure time 2025-10-02 23:32:05 - browse：245

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： HHS names first

knowledge

WSS

HHS names first

AstraZeneca to buy developer of next

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Positive childhood experiences can help future health

hotspot

explore

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Drug repurposing or repositioning? The language matters

Idaho abortion case may prompt more restrictions in other states

ChatGPT in medicine: STAT answers readers' burning questions

Creating egg and sperm cells from stem cells raises ethical issues

In age of alternative facts, a scholarly course on calling out crap

AstraZeneca to buy developer of next

Malaria cases in Florida and Texas: Here’s what you need to know

Designating disabled people as health disparity population is crucial

focus

Generative AI mines health records to identify patients’ social needs

5 to watch: Tech startups trying to solve health care's staffing crisis

New menopause drug shows promise in relief for hot flashes

Colonoscopy prep: Liquid

Stop the failed accountable care organization experiment

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

knowledge

entertainment

focus

Wikipedia